Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033

摘要

ImportanceInitial results of this intergroup trial of imatinib for patients with metastatic/ unresectable GIST were reported in 2008 (). Updated results reported here show long-term survival with a significant subset of patients surviving 10 or more years, as well as new molecular disease insights.